Inactive Instrument

All News Tryp Therapeutics Inc. Canadian Securities Exchange

Equities

Tryptamine Therapeutics Begins to Trade on ASX; Shares Surge 118%	05-29	MT
Tryp Therapeutics Files Amended Financial Statements for the Six Months Ended February 29, 2024	05-17	NE
Tryptamine Therapeutics Limited Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	04-29	CI
3,043,860 Common Shares of Tryptamine Therapeutics Limited are subject to a Lock-Up Agreement Ending on 18-DEC-2023.	12-17	CI
3,043,860 Common Shares of Tryptamine Therapeutics Limited are subject to a Lock-Up Agreement Ending on 20-JUN-2023.	19/06/23	CI

No results for this search